159 related articles for article (PubMed ID: 6987048)
41. The antibody response in infants after colonization of the intestine with E. coli O83. Artificial colonization used as a prevention against nosocomial infections.
Lodinová-Zádníková R; Tlaskalová H; Bartáková Z
Adv Exp Med Biol; 1991; 310():329-35. PubMed ID: 1809007
[No Abstract] [Full Text] [Related]
42. Maternal activation of the EGFR prevents translocation of gut-residing pathogenic
Knoop KA; Coughlin PE; Floyd AN; Ndao IM; Hall-Moore C; Shaikh N; Gasparrini AJ; Rusconi B; Escobedo M; Good M; Warner BB; Tarr PI; Newberry RD
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7941-7949. PubMed ID: 32179676
[TBL] [Abstract][Full Text] [Related]
43. [Secretory immunoglobulin A in human milk and infants' feces at 1-4 months after delivery].
Wang F; Shi C
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):588-90. PubMed ID: 8745502
[TBL] [Abstract][Full Text] [Related]
44. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
45. Antibodies against Escherichia coli capsular (K) antigens in human milk and serum. Their relation on the E. coli gut flora of the mother and neonate.
Carlsson B; Kaijser B; Ahlstedt S; Gothefors L; Hansson LA
Acta Paediatr Scand; 1982 Mar; 71(2):313-8. PubMed ID: 6753474
[No Abstract] [Full Text] [Related]
46. Transformation of pathogenic Shigella-like E. Coli strains into attenuated strains for preventive and therapeutical purposes.
Istrati G; Meitert T; Ciufecu C; Sulea IT; Baron E; Buşoi C
Zentralbl Bakteriol Orig A; 1972 Dec; 222(3):342-8. PubMed ID: 4145496
[No Abstract] [Full Text] [Related]
47. [The influence of nutrition on the course of nosocomial infections with Salmonella infantis and pathogenic strains of Escherichia coli in premature infants and newborns].
Dluholucký S; Stefanovic P; Ruttkay F; Pelikánová G
Cesk Pediatr; 1980 Jul; 35(7):340-2. PubMed ID: 6998580
[No Abstract] [Full Text] [Related]
48. Prevention and treatment of gastrointestinal infections in infants by using immunobiologic methods.
Lodinová R; Korych B; Bartáková Z; Braná H
Zentralbl Gynakol; 1984; 106(11):782-6. PubMed ID: 6382882
[No Abstract] [Full Text] [Related]
49. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
[TBL] [Abstract][Full Text] [Related]
50. Immunologic evaluation of an Escherichia coli O157-infected pregnant woman. A case report.
Tanaka H; Toyoda N; Adachi E; Takeda T
J Reprod Med; 2000 May; 45(5):442-4. PubMed ID: 10845182
[TBL] [Abstract][Full Text] [Related]
51. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
[TBL] [Abstract][Full Text] [Related]
52. Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin.
Tsuji T; Shimizu T; Sasaki K; Shimizu Y; Tsukamoto K; Arimitsu H; Ochi S; Sugiyama S; Taniguchi K; Neri P; Mori H
Vaccine; 2008 Jan; 26(4):469-76. PubMed ID: 18093704
[TBL] [Abstract][Full Text] [Related]
53. [Oral immunization of newborn infants with an extract vaccine of dyspepsia coli--a field tt. 2. Organization and conduction of the field test].
Ocklitz HW; Mochmann H; Schmitz HH; Schmidt EF
Padiatr Grenzgeb; 1969; 8(1):13-27. PubMed ID: 4909043
[No Abstract] [Full Text] [Related]
54. Maternal antibodies in breast milk protect the child from enterovirus infections.
Sadeharju K; Knip M; Virtanen SM; Savilahti E; Tauriainen S; Koskela P; Akerblom HK; Hyöty H;
Pediatrics; 2007 May; 119(5):941-6. PubMed ID: 17473095
[TBL] [Abstract][Full Text] [Related]
55. Antibodies in human milk against E. coli of the serogroups most commonly found in neonatal infections.
Gindrat JJ; Gothefors L; Hanson LA; Winberg J
Acta Paediatr Scand; 1972 Sep; 61(5):587-90. PubMed ID: 4559695
[No Abstract] [Full Text] [Related]
56. Bacterial and viral coproantibodies in breast-fed infants.
Kenny JF; Boesman MI; Michaels RH
Pediatrics; 1967 Feb; 39(2):202-13. PubMed ID: 4163495
[No Abstract] [Full Text] [Related]
57. [Importance of dietary prophylaxis in the prevention of gastrointestinal infections in the premature infant].
Nigro N; Garofalo P
Minerva Pediatr; 1966 Apr; 18(15):751-3. PubMed ID: 5952846
[No Abstract] [Full Text] [Related]
58. Protective effects of breastfeeding against urinary tract infection.
Hanson LA
Acta Paediatr; 2004 Feb; 93(2):154-6. PubMed ID: 15046263
[TBL] [Abstract][Full Text] [Related]
59. Otitis media in infants.
Rothstein RL; Bland RD
Pediatrics; 1972 Jul; 50(1):167-8. PubMed ID: 5038099
[No Abstract] [Full Text] [Related]
60. [Contamination of newborn infants during and after delivery (parasitic and viral diseases excluded)].
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):151-64. PubMed ID: 4620278
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
